The incretin landscape: how it compares

Where survodutide sits among the metabolic drugs

Survodutide is one entry in a crowded and fast-moving field. To place it fairly you need the whole map: the proglucagon family of hormones it draws from, the different receptor combinations that define semaglutide, tirzepatide, retatrutide, and cagrilintide, and where a GLP-1-plus-glucagon dual agonist fits among them.

This unit builds that landscape from the biology up, so the comparisons are about mechanism and evidence rather than marketing, and so survodutide real niche, the liver, becomes clear.